SLC26A9 Promotes Colorectal Tumorigenesis by Modulating Wnt/β-Catenin Signaling

Researchers explored the role of solute carrier family 26 member 9 (SLC26A9) in colorectal cancer (CRC) and its related mechanisms through clinical samples from CRC patients, CRC cell lines and mouse models.